Subgroups	No. of cases	Deaths from breast cancer	Deaths from second cancer	Deaths from benign causes	Probability of cure (95% CI)	5-year survival (95% CI)
Age (y)
<45	311	86	53	98	0.70 (0.65 - 0.75)	0.82 (0.77 - 0.86)
45 - 54	232	60	47	111	0.72 (0.66 - 0.78)	0.82 (0.77 - 0.87)
55 - 64	161	48	35	77	0.66 (0.58 - 0.74)	0.76 (0.69 - 0.82)
≥65	59	10	8	40	0.60 (0.00 - 1・00)	0.64 (0.52 - 0.77)
Stage
I	217	34	46	95	0.82 (0.77 - 0.88)	0.88 (0.84 - 0.93)
IIa	219	50	45	96	0.74 (0.67 - 0.81)	0.86 (0.81 - 0.93)
IIb	227	67	39	101	0.65 (0.58 - 0.72)	0.75 (0.69 - 0.80)
IIIa	100	53	13	34	0.40 (0.30 - 0.51)	0.54 (0.44 - 0.64)
T disease
T1	290	59	59	122	0.77 (0.72 - 0.82)	0.87 (0.83 - 0.90)
T2	367	101	72	158	0.74 (0.67 - 0.81)	0.78 (0.74 - 0.83)
T3	106	44	12	46	0.54 (0.43 - 0.64	0.61 (0.52 - 0.71)
N disease
N0	397	71	81	178	0.80 (075 - 0.84)	0.86 (0.83 - 0.89)
N1	323	104	57	139	0.63 (057 - 0.69)	0.75 (0.71 - 0.80)
N2	43	29	5	9	0.10 (0.00 - 0.24)	0.42 (0.27 - 0.57)
Radiotherapy
(-)	309	68	48	128	0.75 (0.69 - 0.80)	0.83 (0.79 - 0.88)
(+)	445	132	94	194	0.67 (0.62 - 0.72)	0.77 (0.73 - 0.81)
Body weight (kg)
<40	47	5	13	25	0.88 (0.79 - 0.98)	0.83 (0.72 - 0.94)
40 - 59	617	161	119	260	0.70 (0.66 - 0.74)	0.81 (0.72 - 0.94)
60 - 69	84	34	9	35	0.55 (0.43 - 0.66)	0.67 (0.43 - 0.90)
≥70	15	4	2	6	0.69 (0.44 - 0.94)	0.67 (0.57 - 0.78)
Height (cm)
<150	163	40	26	84	0.71 (0.63 - 0.79)	0.80 (0.74 - 0.86)
150 - 159	505	139	97	209	0.69 (0.64 - 0.73)	0.79 (0.75 - 0.82)
≥160	95	25	20	33	0.70 (0.60 - 0.80)	0.80 (0.72 - 0.88)
Body mass index
<18	55	10	17	23	0.77 (0.64 - 0.91)	0.78 (0.67 - 0.89)
18 - 24	586	147	114	251	0.72 (0.68 - 0.76)	0.81 (0.78 - 0.84)
25 - 29	111	42	10	48	0.58 (0.47 - 0.67)	0.73 (0.65 - 0.81)
≥30	11	5	2	4	0.54 (0.25 - 0.84)	0.54 (0.25 - 0.84)
Metastasis
(−)	576	31	137	319	0.83 (0.80 - 0.86)	0.85 (0.82 - 0.88)
(+)	178	169	5	3	0.03 (0.00 - 0.09)	0.52 (0.43 - 0.60)
Locoreg rec
(−)	715	169	140	318	0.72 (0.68 - 0.76)	0.81 (0.78 - 0.84)
(+)	39	31	2	4	0.14 (0.02 - 0.25)	0.51 (0.42 - 0.60)